Mun Lee - Daihan Pharmaceutical Non-Executive Independent Director
| 023910 Stock | KRW 27,250 600.00 2.25% |
Director
Lee Mun Seon is NonExecutive Independent Director of DaehanPharmaceutical. Prior to that Lee worked for Choheung Bank. Lee holds a Bachelor degree in Business Administration from Sungkyunkwan University Korea.
| Age | 68 |
| Phone | 82 2 2678 3911 |
| Web | https://www.daihan.com |
Daihan Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of 0.0677 % which means that it generated a profit of $0.0677 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 12.4908 %, meaning that it generated $12.4908 on every $100 dollars invested by stockholders. Daihan Pharmaceutical's management efficiency ratios could be used to measure how well Daihan Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | DIRECTOR Age | ||
| KeeHong Woo | Korean Air Lines | 60 | |
| SooKeun Lee | Korean Air Lines | 62 | |
Management Performance
| Return On Equity | 12.49 | |||
| Return On Asset | 0.0677 |
Daihan Pharmaceutical Leadership Team
Elected by the shareholders, the Daihan Pharmaceutical's board of directors comprises two types of representatives: Daihan Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Daihan. The board's role is to monitor Daihan Pharmaceutical's management team and ensure that shareholders' interests are well served. Daihan Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Daihan Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yun Lee, Chief Executive Officer, Director | ||
| Dong Lee, President Director | ||
| YoonWoo Lee, Chairman Officer | ||
| Myeong Yim, Internal Auditor | ||
| Mun Lee, Non-Executive Independent Director | ||
| Bok Yum, Director |
Daihan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Daihan Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 12.49 | |||
| Return On Asset | 0.0677 | |||
| Profit Margin | 0.10 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 148.23 B | |||
| Shares Outstanding | 6 M | |||
| Shares Owned By Insiders | 34.84 % | |||
| Shares Owned By Institutions | 13.66 % | |||
| Price To Earning | 11.74 X | |||
| Price To Sales | 0.93 X |
Pair Trading with Daihan Pharmaceutical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Daihan Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daihan Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.Moving together with Daihan Stock
Moving against Daihan Stock
The ability to find closely correlated positions to Daihan Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Daihan Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Daihan Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Daihan Pharmaceutical CoLtd to buy it.
The correlation of Daihan Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Daihan Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Daihan Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Daihan Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Daihan Stock
Daihan Pharmaceutical financial ratios help investors to determine whether Daihan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Daihan with respect to the benefits of owning Daihan Pharmaceutical security.